Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

THAER KHOURY

Allopathic & Osteopathic Physicians Pathology Anatomic Pathology

NPI
1316043839
CMS profile
570700
Location
BUFFALO, NY

General Payments · PY2021–2024

$62,454.86

  • Reported across 39 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$20,314.66

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $10,618.63 8
Roche Diagnostics Corporation $9,619.96 6
GlaxoSmithKline, LLC. $76.07 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $8,318.75 5
PY2022 $24,855.56 11
PY2023 $8,965.89 8
PY2024 $20,314.66 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $907.50 02/13/2024 Consulting Fee Undisputed 01/23/2026 1105771440 CMS
AstraZeneca Pharmaceuticals LP $3,932.50 03/08/2024 Consulting Fee Undisputed 01/23/2026 1105298269 CMS
AstraZeneca Pharmaceuticals LP $31.13 03/26/2024 Food and Beverage Undisputed 01/23/2026 1105463389 CMS
AstraZeneca Pharmaceuticals LP $1,210.00 05/07/2024 Consulting Fee Undisputed 01/23/2026 1105598455 CMS
AstraZeneca Pharmaceuticals LP $907.50 05/16/2024 Consulting Fee Undisputed 01/23/2026 1105734199 CMS
AstraZeneca Pharmaceuticals LP $1,815.00 06/10/2024 Consulting Fee Undisputed 01/23/2026 1105505338 CMS
AstraZeneca Pharmaceuticals LP $907.50 07/05/2024 Consulting Fee Undisputed 01/23/2026 1105840429 CMS
AstraZeneca Pharmaceuticals LP $907.50 11/07/2024 Consulting Fee Undisputed 01/23/2026 1105577552 CMS
GlaxoSmithKline, LLC. $76.07 04/26/2024 Food and Beverage Undisputed 01/23/2026 1116064347 CMS
Roche Diagnostics Corporation $20.00 08/15/2024 Travel and Lodging Undisputed 01/23/2026 1089611306 CMS
Roche Diagnostics Corporation $698.76 08/15/2024 Travel and Lodging Undisputed 01/23/2026 1089611308 CMS
Roche Diagnostics Corporation $5,562.50 11/05/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1089611316 CMS
Roche Diagnostics Corporation $1,112.90 11/27/2024 Travel and Lodging Undisputed 01/23/2026 1089611310 CMS
Roche Diagnostics Corporation $1,112.90 11/27/2024 Travel and Lodging Undisputed 01/23/2026 1089611312 CMS
Roche Diagnostics Corporation $1,112.90 11/27/2024 Travel and Lodging Undisputed 01/23/2026 1089611314 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.